Jeonjinbio Co. Ltd (110020) — Capital Reinvestment Ratio
Latest as of September 2025:
0.03x
Jeonjinbio Co. Ltd (110020) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩313.21 Million) in capital expenditures (₩10.04 Million). See Jeonjinbio Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
₩313.21 Million
KRW
Capital Expenditures
₩10.04 Million
KRW
Data as of
Sep 2025
Most recent filing
Jeonjinbio Co. Ltd Capital Reinvestment Ratio (2024–2024)
This chart tracks Jeonjinbio Co. Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Jeonjinbio Co. Ltd (2024–2024)
Year-by-year Capital Reinvestment Ratio for Jeonjinbio Co. Ltd from 2024 to 2024. For live market cap and broader valuation context, see Jeonjinbio Co. Ltd (110020) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | ₩3.01 Billion | ₩394.36 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow